• SENSEX 81,035.20
    -338.55 (--0.42%)
  • BANKNIFTY 55,903.40
    153.70 (+0.28%)
  • Yes Bank
    21.55 16.02(%)
  • Vodafone Idea
    6.75 6.46(%)
  • Aptus Value Hou.
    305.00 267.75(%)
  • Zinka Logistics
    420.00 248.25(%)
  • Bombay Dyeing
    159.05 256.25(%)
  • Ola Electric
    50.75 45.55(%)
  • Reliance Power
    58.86 23.26(%)
  • Suzlon Energy
    68.81 45.13(%)
  • Garden Reach Sh.
    3,049.00 3,143.00(%)
  • Reliance Infra.
    340.15 143.70(%)
  • Eternal Ltd
    245.95 304.50(%)
  • Shilchar Tech.
    8,264.00 8,899.00(%)
  • Mazagon Dock
    3,440.90 3,778.00(%)
  • KFin Technolog.
    1,170.00 1,640.00(%)
  • Trident
    33.09 41.79(%)
  • Adani Ports
    1,428.30 993.85(%)
  • Adani Green
    988.30 758.00(%)
  • Inox Wind
    189.30 262.10(%)
  • Cochin Shipyard
    1,980.00 2,977.10(%)
  • Nisus Finance
    282.10 224.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 72610.0
  • ISIN : INE338H01029
1,819.40 71 (4.05%)
  • As on 03 Jun 2025 (EOD)

  • Today’s Low

    1,755.40

  • Today’s High

    1,834.90

  • Open

    1,763.10

  • Perv Close

    1,748.50

  • 52W Low

    1,327.05

  • 52W High

    2,664.00

Key Indicators

  • P/E(TTM)

    51.12

  • Mar.Cap (₹Cr.)

    19,033.87

  • Div & Yield %

    0.59

  • Book Value(₹)

    173.27

  • Debt-Equity Ratio

    4.05

  • AGM Date

    02-Jun-2025

  • EPS

    35.65

  • P/E Ratio

    51.12

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    19,033.87

  • RONW (%)

    21.88

  • ROCE (%)

    29.05

Score Board

  • Equity (₹ in Cr.)

    10.46

  • BV (₹)

    173.30

  • Sales( ₹ in Cr.)

    1,200.09

  • NP (in Cr.)

    372.96

  • NP Var(%)

    27.0

  • Div%

    1070.0

  • CPS (₹)

    40.80

  • EPS (₹)

    35.70

  • Traded Value (₹ in Lakhs)

    19,065.78

  • 52 Week High

    2,664.00

  • 52 Week Low

    1,327.05

  • Price BSE

    1822.0

  • Price NSE

    1,819.00

  • Market Capital( in Cr.)

    19,065.78

  • P/C Ratio

    44.60

  • P/E Ratio

    51.10

  • Price Vs.BV

    35.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,016.94 853.17 712.93 616.94 512.33 436.01
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,016.94 853.17 712.93 616.94 512.33 436.01
Other Income 33.78 35.31 23.42 13.81 31.37 17.44
Stock Adjustments 12.08 15.63 23.98 39.05 4.85 1.16
Total Income 1,062.80 904.11 760.33 669.80 548.55 454.61
EXPENDITURE :            
Raw Materials 241.28 195.84 187.99 150.61 134.79 109.17
Power and Fuel Cost 104.97 97.65 71.64 39.86 37.30 36.29
Employee Cost 123.05 110.28 95.69 69.47 62.24 48.08
Other Manufacturing Expenses 28.00 24.93 17.10 12.99 30.93 12.53
Selling and Administration Expenses 91.08 82.93 67.90 44.87 31.74 35.72
Miscellaneous Expenses 8.46 13.20 22.66 10.26 15.65 14.90
Employee Benefit Expenses 123.05 110.28 95.69 69.47 62.24 48.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 596.83 524.84 462.99 328.05 312.65 256.69
Operating Profit 465.97 379.27 297.34 341.74 235.91 197.92
Interest 3.18 5.18 6.13 1.05 1.17 0.69
Gross Profit 462.79 374.09 291.21 340.69 234.74 197.23
Depreciation 53.59 54.03 50.05 27.52 21.25 19.31
Profit Before Tax 409.20 320.06 241.16 313.17 213.49 177.92
Current Tax 99.83 79.53 58.49 75.72 54.53 55.62
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.63 2.40 4.10 2.11 -10.00 3.91
Reported Net Profit 304.73 238.13 178.57 235.33 168.96 118.39
Extraordinary Items 10.48 2.70 3.86 5.24 17.47 1.53
Adjusted Net Profit 294.25 235.43 174.71 230.09 151.49 116.86
Adjustment below Net Profit -0.01 0.26 -0.56 -0.04 -0.84 0.14
P & L Balance brought forward 1,170.33 985.51 878.02 648.43 560.85 472.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 71.45 53.56 70.52 5.71 80.55 30.38
P & L Balance carried down 1,403.60 1,170.33 985.51 878.02 648.43 560.85
Dividend 0.00 0.00 0.00 0.00 0.00 25.20
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 875.00 683.00 51.20 0.00 392.50 264.50
Dividend Per Share(Rs) 8.75 6.83 5.12 0.00 39.25 26.45
Earnings Per Share-Unit Curr 29.13 22.76 187.76 247.44 177.66 124.48
Earnings Per Share(Adj)-Unit Curr 29.13 - - - - -
Book Value 145.80 123.50 1,164.13 1,051.11 809.71 717.62
Book Value(Adj)-Unit Curr 145.80 - - - - -

Shareholding Pattern

  • Promoter Group

    44.08%

  • Public Share Holding

    55.92%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,752,000 4.54 4,752,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,364,608 39.54 41,364,608 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 46,116,608 44.08 46,116,608 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,781,939 9.35 9,781,939 92
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,504,495 3.35 3,504,495 6
Mutual Funds / UTI 5,394,790 5.16 5,394,790 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 680,595 0.65 680,595 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 19,361,819 18.51 19,361,819 128
2] Non Institution
Bodies Corporate 1,771,484 1.69 1,771,484 535
Clearing Members 259 0.00 259 1
Directors of their Relatives 210,000 0.20 210,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 2,092,325 2.00 2,092,325 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,274,629 2.17 2,274,629 1,162
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 195,881 0.19 195,881 2,536
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,406,432 1.34 1,406,432 1
Individuals holding nominal share capital up to Rs. 1 lakh 5,855,499 5.60 5,855,499 76,841
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 25,314,468 24.20 25,314,468 6
Others 16,800 0.02 16,800 1
Sub Total 39,137,777 37.41 39,137,777 81,085
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 104,616,204 100.00 104,616,204 81,219

Company Background

Concord Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Biotech Ltd
  • BSE Code : 72610.0
  • ISIN : INE338H01029

  • Incorporation Year

    1984

  • Registered Office

    1482-86 Trasad Road
    Dholka, Ahmedabad,
    Gujarat-382225

  • Telephone

    91-079-68138700

  • FAX

  • Chairman

    SUDHIR JAIRAM VAID

  • Managing Director

    SUDHIR JAIRAM VAID

  • Company Secretary

    S Prakash

  • Auditor

    Deloitte Haskins & Sells/BSR & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Concord Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Biotech 1,822.45 1,050.72 1,016.94 51.12 28.81
Abbott India 30,663.80 6,097.18 5,848.91 46.07 44.71
Astrazeneca Phar 9,315.65 1,330.33 1,295.53 201.20 33.26
P & G Health Ltd 5,758.05 1,166.89 1,151.26 38.05 39.76
Glaxosmi. Pharma 3,271.55 3,530.73 3,407.25 60.31 44.44
Cipla 1,469.75 17,645.00 16,574.34 23.02 20.10
Amrutanjan Healt 719.00 437.58 421.23 40.90 20.84
Fermenta Biotec. 318.15 315.24 307.09 13.85 4.10
Guj. Themis Bio. 309.40 174.19 169.82 69.06 44.82
Bliss GVS Pharma 133.80 638.96 605.46 20.43 11.19
Ambalal Sarabhai 37.10 11.70 3.81 34.35 1.92